Recombinant Schizosaccharomyces pombe U6 snRNA-associated Sm-like protein LSm5 (lsm5)

Shipped with Ice Packs
In Stock

Description

Recombinant Production and Purification

The protein is expressed and purified using standardized protocols:

Cloning and Expression

  • Host Systems: E. coli, yeast, or mammalian cells .

  • Vector: pETDuet-1 or pACYCDuet-1 with N-terminal His₆-tag .

  • Gene Source: Full-length lsm5 amplified via RT-PCR from S. pombe genomic DNA .

Purification

  • Purity: ≥85% (SDS-PAGE) .

  • Storage: Stable at -20°C or -80°C; glycerol (5–50%) recommended for long-term storage .

Functional Roles

Lsm5 is integral to RNA metabolism, with specific roles in:

U6 snRNP Assembly

  • Stabilizes U6 snRNA by forming a heterohexameric ring (Lsm5/6/7) that binds the 3′ end of U6 snRNA .

  • Facilitates U4/U6 duplex formation via interactions with Prp24, a chaperone protein .

RNA Decay and Processing

  • Participates in mRNA decay by recognizing 3′ oligoadenylated or uridylated RNAs .

  • Protects viral mRNAs with 5′ poly(A) tracts from exonucleolytic degradation .

Experimental Applications

Recombinant Lsm5 is utilized in:

Biochemical Assays

  • RNA Binding: Surface plasmon resonance (SPR) and fluorescence anisotropy confirm oligo(U) specificity .

  • Structural Studies: Crystallography and analytical ultracentrifugation define oligomerization states .

Functional Complementation

  • Suppresses growth defects in S. cerevisiae Lsm-depleted strains when U6 snRNA is overexpressed .

Key Research Findings

  • Dynamic Oligomerization: Lsm4 exists in monomer-trimer equilibrium, while Lsm5/6/7 forms stable hexamers .

  • Species-Specific Adaptations: S. pombe Lsm8 C-terminus diverges from S. cerevisiae, influencing RNA-binding specificity .

Future Directions

  • Mechanistic Studies: Elucidate Lsm5’s role in viral mRNA stabilization and miRNA biogenesis.

  • Therapeutic Targets: Explore Lsm complexes as targets for RNA-centric therapies.

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format. If you have specific format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. For dry ice shipping, contact us in advance; extra fees apply.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
lsm5; SPBC20F10.09U6 snRNA-associated Sm-like protein LSm5
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-80
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)
Target Names
lsm5
Target Protein Sequence
MSMTILPLEL IDKCIGSNLW VIMKSEREFA GTLVGFDDYV NIVLKDVTEY DTVTGVTEKH SEMLLNGNGM CMLIPGGKPE
Uniprot No.

Target Background

Function
Component of LSm protein complexes involved in RNA processing. LSm5 is required for pre-tRNA, pre-rRNA, and U3 snoRNA processing and may function as a chaperone.
Database Links
Protein Families
SnRNP Sm proteins family
Subcellular Location
Nucleus.

Q&A

What is the basic structure of S. pombe Lsm5 protein?

S. pombe Lsm5 shares the conserved Sm fold characteristic of all Sm-like proteins. Crystallographic studies have revealed that Lsm5, like other Lsm proteins, adopts this canonical fold consisting of an N-terminal α-helix followed by five β-strands arranged in an antiparallel manner. This structural organization enables Lsm5 to participate in the formation of ring-shaped heteromeric complexes with other Lsm proteins. The structural data indicates that the Sm fold is essential for mediating protein-protein interactions between adjacent subunits in these complexes, as well as for RNA binding functions .

What oligomeric states does recombinant S. pombe Lsm5 form?

Recombinant S. pombe Lsm5 primarily exists as part of a hexameric Lsm5/6/7 sub-complex in solution, as demonstrated by analytical ultracentrifugation studies. Unlike Lsm3, which forms heptamers, or Lsm4, which exhibits a dynamic equilibrium between monomeric and trimeric states, the Lsm5/6/7 complex forms a stable hexamer. This hexameric formation is significant for understanding how Lsm5 contributes to larger assemblies like the Lsm2-8 complex that functions in U6 snRNA binding and stabilization .

What is the role of Lsm5 in RNA processing within S. pombe?

Lsm5 functions as an integral component of the U4/U6-U5 tri-snRNP complex that plays a crucial role in spliceosome assembly and pre-mRNA splicing. As part of the heptameric Lsm2-8 complex, Lsm5 contributes to the specific binding and stabilization of the 3'-terminal poly(U) tract of U6 snRNA. This interaction is essential for protecting U6 snRNA from degradation and for facilitating the incorporation of U6 snRNA into the spliceosome during assembly. Additionally, Lsm5 participates in the formation of the precatalytic spliceosome (spliceosome B complex), which is necessary for the progression of the splicing reaction .

What expression systems are optimal for producing recombinant S. pombe Lsm5?

Escherichia coli represents the preferred expression system for producing recombinant S. pombe Lsm5 protein due to its efficiency and scalability. The methodology typically involves cloning the Lsm5 gene into expression vectors like pETDuet-1, which allows for the inclusion of an N-terminal His6-tag to facilitate purification. For co-expression with other Lsm proteins, the Lsm5 gene can be inserted into the multiple cloning site 1 (MCS1) of the pETDuet-1 vector, while complementary Lsm genes (such as Lsm6) can be inserted into MCS2. This approach enables the production of stable Lsm5-containing complexes, which often exhibit better solubility and stability than individual Lsm proteins expressed in isolation .

What purification strategy should be employed for recombinant S. pombe Lsm5?

A multi-step purification strategy is recommended for obtaining high-purity recombinant S. pombe Lsm5 or Lsm5-containing complexes. The initial step typically involves immobilized metal affinity chromatography (IMAC) using the N-terminal His6-tag, followed by size exclusion chromatography to isolate the correctly assembled complexes and remove aggregates. For structural studies requiring the highest purity, additional steps such as ion exchange chromatography may be necessary. When purifying Lsm5 as part of complexes (e.g., Lsm5/6/7), maintaining appropriate buffer conditions is critical to preserve the native oligomeric state. Typical buffer systems include 20 mM HEPES pH 7.5, 150 mM NaCl, and 1 mM DTT, with the inclusion of protease inhibitors during initial extraction steps to prevent degradation .

What methods can be used to verify the correct folding and assembly of recombinant Lsm5?

Multiple analytical techniques should be employed to confirm the proper folding and assembly of recombinant Lsm5. Analytical ultracentrifugation can determine the oligomeric state of the protein, which is critical for confirming whether Lsm5 has assembled into the expected hexameric Lsm5/6/7 complex. Circular dichroism spectroscopy provides information about secondary structure content, verifying the presence of the characteristic α-helix and β-strands of the Sm fold. Additionally, functional RNA binding assays using fluorescence anisotropy or surface plasmon resonance with oligo(U) substrates can confirm that the recombinant protein retains its biological activity. For ultimate validation, crystallization trials followed by X-ray diffraction analysis provide definitive evidence of correct folding and assembly, as has been demonstrated for the Lsm5/6/7 complex from S. pombe .

What RNA sequences does S. pombe Lsm5 preferentially bind to?

S. pombe Lsm5, particularly as part of the Lsm5/6/7 complex, demonstrates specific binding affinity for oligo(U) sequences. This preference for uridine-rich regions is consistent with the biological role of Lsm proteins in recognizing the 3'-terminal poly(U) tract of U6 snRNA. RNA binding assays have confirmed that while the Lsm5/6/7 sub-complex readily binds to oligo(U), isolated subunits like Lsm3 or Lsm4 do not exhibit detectable RNA binding when tested independently. This suggests that the correctly assembled multimeric complex is necessary for effective RNA recognition, with the binding pocket likely formed at the interface between adjacent subunits. The specificity for oligo(U) sequences is critical for the biological function of Lsm5 in stabilizing U6 snRNA and facilitating spliceosome assembly .

What experimental approaches can be used to measure Lsm5-RNA interactions?

Several complementary techniques can be employed to characterize and quantify Lsm5-RNA interactions:

  • Surface Plasmon Resonance (SPR): This technique allows real-time measurement of binding kinetics between immobilized RNA (typically biotinylated oligo(U) sequences) and flowing Lsm5 or Lsm5-containing complexes. SPR provides association and dissociation rate constants as well as equilibrium binding constants.

  • Fluorescence Anisotropy: Using fluorescently labeled RNA oligonucleotides, this method measures changes in rotational diffusion upon binding to Lsm5 complexes. It is particularly useful for determining binding affinities and can be performed in solution.

  • Electrophoretic Mobility Shift Assay (EMSA): This gel-based technique detects the formation of RNA-protein complexes through shifts in electrophoretic mobility compared to free RNA. It provides qualitative confirmation of binding and can indicate binding stoichiometry.

  • UV Crosslinking: This approach identifies the specific amino acid residues involved in RNA binding by crosslinking protein-RNA complexes followed by mass spectrometry analysis.

Experimental data indicate that the Lsm5/6/7 complex binds to oligo(U) with micromolar affinity, which is consistent with its biological role in recognizing U6 snRNA .

How does the RNA binding activity of Lsm5 compare within different Lsm subcomplexes?

The RNA binding activity of Lsm5 varies significantly depending on the subcomplex context. Experimental evidence demonstrates that:

  • Lsm5/6/7 Complex: This hexameric complex exhibits robust binding to oligo(U) sequences, suggesting that the proper assembly of these three subunits creates functional RNA binding surfaces.

  • Lsm2/3 Complex: This complex also demonstrates binding to oligo(U), indicating that different Lsm subcomplexes can form functionally active RNA binding units.

  • Individual Lsm3 or Lsm4: No detectable RNA binding was observed for these isolated subunits, highlighting the importance of the correctly assembled multimeric complex for RNA recognition.

These comparative binding studies suggest that Lsm5 contributes essential elements to the RNA binding pocket in the context of the Lsm5/6/7 complex, but its exact contribution may differ in other complexes such as the complete Lsm2-8 heptamer that functions in U6 snRNA binding. The analysis of inter-subunit interactions in the Lsm5/6/7 complex further reveals that Lsm5 serves as a bridge between Lsm6 and Lsm7, suggesting a crucial organizational role in establishing the proper architecture for RNA binding .

What insights have crystallographic studies provided about S. pombe Lsm5's structure and interactions?

Crystallographic studies have revealed several crucial aspects of S. pombe Lsm5's structure and interactions:

  • Conserved Sm Fold: The crystal structure of the Lsm5/6/7 sub-complex confirmed that Lsm5 adopts the canonical Sm fold, consisting of an N-terminal α-helix followed by five β-strands. This structural conservation underscores the evolutionary importance of this fold for Lsm protein function.

  • Hexameric Assembly: Within the crystal lattice, the Lsm5/6/7 complex forms a hexamer, and analytical ultracentrifugation confirmed this oligomeric state exists in solution as well. This differs from the heptameric assemblies observed for some other Lsm complexes, suggesting functional specialization.

  • Inter-subunit Organization: The crystal structure revealed that Lsm5 plays a pivotal bridging role between Lsm6 and Lsm7 within the complex. This organizational arrangement provides insights into how the complete Lsm2-8 ring might be assembled in vivo.

  • RNA Binding Surfaces: The structure identified potential RNA binding surfaces formed at the interfaces between subunits, consistent with the observed ability of the Lsm5/6/7 complex to bind oligo(U) sequences.

These structural insights help explain how Lsm5 contributes to both the architecture and function of Lsm complexes involved in RNA processing pathways .

How does the structure of S. pombe Lsm5 compare to homologous proteins in other organisms?

Structural comparisons between S. pombe Lsm5 and its homologs in other organisms reveal both conserved features and organism-specific variations:

  • Human LSM5: Human LSM5 shares the conserved Sm fold with S. pombe Lsm5, with high sequence similarity particularly in the core structural elements. The human protein is 91 amino acids in length, comparable to the S. pombe counterpart.

  • S. cerevisiae Lsm5: The budding yeast homolog maintains the core structural elements but shows some variations in loop regions and terminal extensions that may reflect adaptation to species-specific RNA processing mechanisms.

  • Conserved RNA Binding Determinants: Across species, the residues involved in RNA recognition, particularly those that interact with uridine bases, show a high degree of conservation, reflecting the fundamental importance of U-rich sequence recognition.

  • Variable C-terminal Regions: While the Sm fold is highly conserved, the C-terminal regions of Lsm proteins can vary between species. These variations may contribute to species-specific interactions with RNA or other proteins in the splicing machinery.

The structural conservation across evolutionary distance underscores the fundamental importance of Lsm5's role in RNA metabolism, while the subtle variations may reflect adaptation to organism-specific regulatory mechanisms .

What are the critical residues in S. pombe Lsm5 that mediate protein-protein and protein-RNA interactions?

Analysis of the Lsm5/6/7 crystal structure has identified several key residues in S. pombe Lsm5 that mediate important interactions:

  • Protein-Protein Interfaces:

    • Residues in β-strands 4 and 5 of Lsm5 form critical contacts with β-strands 5 and 4 of adjacent Lsm6, respectively, through backbone hydrogen bonding and side-chain interactions.

    • The interface between Lsm5 and Lsm7 involves similar β-strand complementation, creating a continuous β-sheet across the subunit boundary.

    • Hydrophobic residues in these interface regions contribute to the stability of the complex.

  • RNA Binding Residues:

    • Basic and aromatic residues within the inner surface of the ring structure are likely involved in RNA binding, particularly in recognizing uridine bases.

    • Conserved residues in loops 3 and 5 (connecting β-strands) face the central pore of the ring structure and are prime candidates for direct RNA contacts.

    • Positively charged residues create an electropositive surface that attracts the negatively charged RNA backbone.

  • Bridging Function:

    • The analysis of the Lsm5/6/7 structure revealed that Lsm5 plays a crucial organizing role by bridging the interaction between Lsm6 and Lsm7, suggesting that specific residues in Lsm5 are essential for maintaining the proper architecture of the complex.

These structural insights provide a molecular basis for understanding how mutations in Lsm5 might affect complex assembly, stability, and RNA binding function, offering potential targets for structure-based investigations of Lsm5's role in RNA processing .

How can researchers study the function of Lsm5 in the context of S. pombe splicing?

Researchers can employ several complementary approaches to investigate Lsm5's function in S. pombe splicing:

  • Gene Disruption/Mutation Studies: Creating lsm5 mutants or knockout strains using techniques like CRISPR-Cas9 or traditional homologous recombination allows assessment of the phenotypic consequences. Since splicing is essential, conditional alleles may be necessary for studying vital functions.

  • RNA-seq Analysis: Comparing transcriptome profiles between wild-type and lsm5 mutant strains can reveal global splicing defects, identifying introns whose splicing depends particularly on Lsm5 function.

  • Co-immunoprecipitation Studies: Using tagged versions of Lsm5, researchers can isolate associated complexes and identify interacting partners through mass spectrometry, confirming Lsm5's incorporation into the U4/U6-U5 tri-snRNP and other relevant complexes.

  • RT-PCR Analysis of Splicing Efficiency: Targeted analysis of specific introns using RT-PCR can quantify splicing defects in lsm5 mutants, revealing the extent to which different pre-mRNAs depend on Lsm5 function.

  • ChIP-seq or CLIP-seq Approaches: These techniques can map Lsm5's binding sites across the transcriptome, identifying direct RNA targets and providing insights into its genome-wide role in RNA processing.

These methodological approaches allow researchers to connect the structural and biochemical properties of Lsm5 to its functional roles in cellular RNA metabolism, particularly in the context of the spliceosome assembly and function .

What is the relationship between S. pombe Lsm5 and the U6 snRNA 3'-end recognition?

S. pombe Lsm5, as part of the heptameric Lsm2-8 complex, plays a crucial role in recognizing and binding to the 3'-terminal poly(U) tract of U6 snRNA. This interaction has several important consequences:

  • U6 snRNA Stabilization: The binding of the Lsm2-8 complex to the 3'-end of U6 snRNA protects it from exonucleolytic degradation, thus maintaining adequate levels of this essential splicing factor.

  • 3'-end Chemistry Recognition: While direct structural data for S. pombe Lsm5 interaction with U6 snRNA is limited, studies of related Lsm proteins suggest that specific residues recognize both the uridine bases and potentially the terminal phosphate chemistry of U6 snRNA.

  • Spliceosome Assembly Facilitation: This specific binding of the Lsm2-8 complex to U6 snRNA is an early and critical step in the assembly of the U4/U6.U5 tri-snRNP, a major subcomplex of the spliceosome.

  • Evolutionary Conservation: The mechanism of U6 snRNA 3'-end recognition appears to be conserved across species, though with some variations in specific interactions. Studies of the C-terminal region of Lsm8 (another component of the Lsm2-8 complex) have suggested that it contains a highly conserved histidine residue that may interact with the terminal uridine base in U6 snRNA or, in metazoans, with the 2',3'-cyclic phosphate group found on U6 RNAs.

This specific recognition of the U6 snRNA 3'-end by the Lsm complex represents a critical regulatory point in the splicing pathway, highlighting the importance of Lsm5's contribution to this essential cellular process .

How does S. pombe Lsm5 function compare to its roles in other organisms?

The function of Lsm5 appears to be broadly conserved across different organisms, though with some species-specific variations:

  • Conserved Core Functions: Across species from yeast to humans, Lsm5 functions as part of the Lsm2-8 complex that binds the 3'-end of U6 snRNA and participates in spliceosome assembly. This conservation reflects the fundamental importance of these processes in eukaryotic gene expression.

  • S. cerevisiae vs. S. pombe: Both yeasts utilize Lsm5 in similar pathways, but there may be differences in the specific interactions with the splicing machinery, reflecting the evolutionary distance between these organisms. For instance, studies have shown differences in the oligomeric states of certain Lsm subcomplexes between the two yeast species.

  • Metazoan Systems: In higher eukaryotes, Lsm5 retains its core role in splicing but may have acquired additional functions in other RNA processing pathways, such as miRNA biogenesis, reflecting the greater complexity of RNA regulatory networks in these organisms.

  • Additional Roles: Unlike in simpler eukaryotes, human LSM5 may participate in cytoplasmic RNA processing as part of the Lsm1-7 complex, which functions in mRNA decay pathways. Whether S. pombe Lsm5 shares this dual nuclear/cytoplasmic functionality remains an area for investigation.

  • Structural Variations: While the core Sm fold is conserved, differences in terminal regions and specific residues may contribute to species-specific functions or interactions, potentially reflecting adaptation to different RNA processing requirements.

These comparative insights highlight both the fundamental conservation of Lsm5's role in RNA metabolism and the potential for species-specific adaptations, suggesting that S. pombe can serve as a valuable model for understanding basic Lsm5 functions while recognizing that some aspects may differ in other organisms .

What are common challenges in expressing and purifying recombinant S. pombe Lsm5, and how can they be addressed?

Researchers frequently encounter several challenges when working with recombinant S. pombe Lsm5:

  • Solubility Issues:

    • Challenge: Lsm5 expressed alone often shows limited solubility due to improper folding or aggregation.

    • Solution: Co-expression with partner proteins (Lsm6 and Lsm7) significantly improves solubility by promoting proper complex formation. Using the pETDuet-1 vector system allows simultaneous expression of multiple Lsm proteins, facilitating complex assembly during expression.

  • Stability Concerns:

    • Challenge: Purified Lsm5 or Lsm5-containing complexes may show instability during storage.

    • Solution: Addition of 5-10% glycerol to storage buffers and maintaining samples at -80°C in small aliquots helps preserve activity. Additionally, including reducing agents like DTT (1-2 mM) prevents oxidative damage.

  • Low Expression Yields:

    • Challenge: Expression levels may be suboptimal, particularly in standard E. coli strains.

    • Solution: Using specialized expression strains like Rosetta(DE3) that provide rare codons, optimizing induction conditions (typically 16-18°C overnight with 0.1-0.5 mM IPTG), and testing different media formulations can significantly improve yields.

  • Protein Degradation:

    • Challenge: Proteolytic degradation during purification can reduce yield and quality.

    • Solution: Including protease inhibitor cocktails during initial extraction steps, maintaining samples at 4°C throughout purification, and minimizing processing time helps preserve protein integrity.

  • Heterogeneous Sample Preparation:

    • Challenge: Obtaining homogeneous preparations of properly assembled complexes.

    • Solution: Rigorous size exclusion chromatography as a final purification step helps isolate homogeneous populations of correctly assembled complexes.

These optimization strategies have been successfully applied in crystallographic studies of S. pombe Lsm complexes, yielding pure, homogeneous samples suitable for structural and functional analyses .

What controls should be included in experiments investigating S. pombe Lsm5 RNA binding?

To ensure robust and interpretable results when studying S. pombe Lsm5 RNA binding, researchers should include these essential controls:

  • Negative Controls:

    • Individual Lsm proteins known not to bind RNA independently (e.g., Lsm3, Lsm4) to demonstrate that any observed binding requires the properly assembled complex.

    • Heat-denatured Lsm5/6/7 complex to confirm that binding requires the native protein structure.

    • Non-U-rich RNA sequences to validate binding specificity for oligo(U).

  • Positive Controls:

    • Well-characterized Lsm complexes with known RNA binding properties, such as the Lsm2/3 complex which has demonstrated oligo(U) binding.

    • If available, the complete Lsm2-8 heptamer as the physiologically relevant complex that binds U6 snRNA.

  • Specificity Controls:

    • Competition assays with unlabeled RNA to confirm specific binding.

    • Dose-response analysis to establish binding constants and compare affinities between different RNA sequences.

    • Salt concentration series to distinguish specific from non-specific electrostatic interactions.

  • Technical Validation:

    • Multiple binding assay methodologies (e.g., both fluorescence anisotropy and SPR) to confirm results across different experimental approaches.

    • Replicate experiments with independently prepared protein samples to ensure reproducibility.

  • Mutational Analysis:

    • Point mutations in predicted RNA-binding residues to correlate structural features with binding function.

    • Tests of truncated constructs to identify essential domains for RNA recognition.

These comprehensive controls help establish the specificity, affinity, and mechanistic basis of Lsm5-RNA interactions while avoiding misinterpretation due to experimental artifacts or non-specific binding .

How can researchers address data inconsistencies when comparing S. pombe Lsm5 with homologs from other species?

When confronting inconsistencies in experimental results between S. pombe Lsm5 and its homologs in other species, researchers should consider the following methodological approaches:

  • Standardize Experimental Conditions:

    • Ensure identical buffer compositions, salt concentrations, pH values, and temperature across experiments with different species' proteins.

    • Use consistent protein-to-RNA ratios and identical RNA substrates when comparing binding properties.

    • Apply the same purification strategies to minimize method-based variability.

  • Direct Comparative Analysis:

    • Express and purify homologs from different species in parallel using identical systems and conditions.

    • Perform side-by-side binding assays rather than comparing historically published data that may have methodological differences.

    • Create chimeric proteins or domain swaps to isolate regions responsible for species-specific differences.

  • Sequence-Structure Analysis:

    • Conduct detailed sequence alignments to identify conserved and divergent regions that may explain functional differences.

    • Map variations to structural models to determine if differences occur in functionally important regions.

    • Use homology modeling when crystal structures are unavailable for certain species' proteins.

  • Consider Biological Context:

    • Evaluate whether differences reflect true biological variation or experimental artifacts.

    • Examine the native RNA targets from each species, as adaptation to species-specific RNA sequences may explain functional differences.

    • Consider the composition of the complete Lsm complexes in different organisms, as variations in partner proteins may influence Lsm5 properties.

  • Validation in Native Systems:

    • Complement in vitro studies with in vivo experiments in the respective organisms.

    • Use genetic complementation tests to determine if Lsm5 from one species can functionally replace its homolog in another species.

By systematically applying these approaches, researchers can distinguish genuine species-specific variations in Lsm5 function from methodological inconsistencies, leading to more accurate comparative analyses across evolutionary distance .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.